Literature DB >> 6508248

Brain methylation and epileptogenesis: the case of methionine sulfoximine.

O Z Sellinger, R A Schatz, R Porta, T E Wilens.   

Abstract

A brief review of the neurochemical effects of the convulsant agent L-methionine-dl-sulfoximine (MSO) on cerebral methylation reactions is presented. Our findings point to the involvement of a number of endogenous methyl acceptor molecules, including histamine, membrane phospholipids, and membrane proteins, in the mediation of the convulsant effect. Our findings also associate the inhibition of methylations by high levels of S-adenosyl-L-homocysteine in brain with protection against MSO-induced seizures. We propose that MSO acts by eliciting the acceleration of a regulatory methylation-demethylation sequence at key molecular sites, including the benzodiazepine receptor complex, which creates an imbalance in this sequence's normal mediation of convulsant-anticonvulsant mechanisms.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6508248     DOI: 10.1002/ana.410160717

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  10 in total

1.  A zebrafish model of hyperammonemia.

Authors:  B Feldman; M Tuchman; L Caldovic
Journal:  Mol Genet Metab       Date:  2014-07-10       Impact factor: 4.797

2.  Down-regulation of S-adenosylhomocysteine hydrolase in the active methyl transfer system in the brain of genetically epileptic El mice.

Authors:  O Ohmori; H Hirano; T Ono; K Abe; T Mita
Journal:  Neurochem Res       Date:  1996-10       Impact factor: 3.996

Review 3.  Astrocyte glutamine synthetase: importance in hyperammonemic syndromes and potential target for therapy.

Authors:  Saul W Brusilow; Raymond C Koehler; Richard J Traystman; Arthur J L Cooper
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

4.  Effects of anti-epileptic drugs on glutamine synthetase activity in mouse brain.

Authors:  C M Fraser; G J Sills; G Forrest; G G Thompson; M J Brodie
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

5.  Effect of glutamine synthetase inhibition on astrocyte swelling and altered astroglial protein expression during hyperammonemia in rats.

Authors:  H Tanigami; A Rebel; L J Martin; T-Y Chen; S W Brusilow; R J Traystman; R C Koehler
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

6.  Glutamine-dependent inhibition of pial arteriolar dilation to acetylcholine with and without hyperammonemia in the rat.

Authors:  Tetsu Kawaguchi; Saul W Brusilow; Richard J Traystman; Raymond C Koehler
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-02-10       Impact factor: 3.619

7.  Dietary supplementation with S-adenosyl methionine was associated with protracted reduction of seizures in a line of transgenic mice.

Authors:  Sheryl Perry; James Levasseur; Amy Chan; Thomas B Shea
Journal:  Comp Med       Date:  2008-12       Impact factor: 0.982

Review 8.  Ketogenic diet, neuroprotection, and antiepileptogenesis.

Authors:  Madhuvika Murugan; Detlev Boison
Journal:  Epilepsy Res       Date:  2020-08-19       Impact factor: 3.045

Review 9.  Adenosinergic signaling in epilepsy.

Authors:  Detlev Boison
Journal:  Neuropharmacology       Date:  2015-09-01       Impact factor: 5.250

Review 10.  Does abnormal glycogen structure contribute to increased susceptibility to seizures in epilepsy?

Authors:  Mauro DiNuzzo; Silvia Mangia; Bruno Maraviglia; Federico Giove
Journal:  Metab Brain Dis       Date:  2014-03-19       Impact factor: 3.584

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.